Any experienced researcher with a doctoral degree and working at a non-Spanish research organization for at least 24 months at the moment of the call publication is eligible to apply for a fellowship from the CIBERDEM Incoming Mobility Programme (CIMP) to take trans-national placements at the research centers members of the CIBERDEM consortium.
Candidates to the CIMP fellowships must fill the application form with:
Complete applications will be evaluated by the Selection Committee. All applicants will receive notification of the outcome of their evaluations individually by email. Final results will be published in this website and the selected candidates will be interviewed before the final decision is made. This will take place within two months after the deadline for each call.
Fellow applicants may propose any research project dealing with Diabetes and fitting the major working areas covered by CIBERDEM.
The current call of CIMP fellowships is open to all the consortium research groups with a vacancy on their research labs. In the next table, the applicants can find, as an orientation, the descriptions of several projects to be developed in the different research groups. The applicants may use these as a guide to prepare their Personal Research Proposal.
Prof. Jesús Balsinde Rodríguez, Instituto de Biología y Genética Molecular, Valladolid, Consejo Superior de Investigaciones Científicas.
Prof. Manuel R. Benito de las Heras, Departamento de Bioquímica y Biología Molecular II, Facultad de Farmacia, Universidad Complutense de Madrid.
Prof. Antonio Zorzano Olarte, Fundació Privada Institut de Recerca Biomèdica, Barcelona.
Prof. Francisco Blanco Vaca, Servei de Bioquímica, Hospital Santa Creu I Sant Pau, Barcelona.
Prof. Fàtima Bosch, Centre de Biotecnologia Animal i Teràpia Gènica (CBATEG), Universitat Autònoma de Barcelona.
Prof. Xavier Correig Blanchar, Universitat Rovira I Virgili, Tarragona.
Prof. Héctor F. Escobar Morreale, Hospital Universitario Ramón y Cajal, Madrid.
Dra. Ana M. Gómez Foix, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona.
Más información
Prof. Ramon Gomis, Pancreatic islets: biomarkers and function, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Esther Koplowitz Center, Barcelona.
Prof. Joan J. Guinovart Cirera, Fundació Privada Institut de Recerca Biomèdica, Barcelona.
Prof. Lluís Masana Marín, Institut d’Investigació Sanitaria Pere Virgili, Hospital Universitari Sant Joan, Reus.
Prof. Eduard Montanya, Servei d’Endocrinologia i Nutrició, Hospital Universitari Bellvitge, Barcelona.
Prof. Ángel Nadal, Instituto de Bioingeniería, Universidad Miguel Hernández, Elche.
Dr. Anna Novials, Metabolic and Molecular Disturbances in Diabetes, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.
Prof. Federico J. C-Soriguer Escofet, Servicio de Endocrinología y Nutrición. Hospital Universitario Carlos Haya, Málaga.
Prof. Mario Vallejo, Instituto de Investigaciones Biomédicas Alberto Sols, Universidad Autónoma de Madrid, Consejo Superior de Investigaciones Científicas.
Dr. Manuel Vázquez Carrera, Pharmacology Unit, Department of Pharmacology, University of Barcelona, Barcelona.
Dr. Joan J. Vendrell Ortega, Endocrinology and Nutrition, Hospital Universitari Joan XXIII (School of Medicine), Institut d'Investigació Sanitària Pere Virgili (IISPV).
Further information on research areas of interest and ongoing research projects can be found in the Annual Reports of the CIBERDEM consortium and through the Scientific Articles published by our members.
Fellow CIMP researchers will be employed by CIBERDEM under a contract basis, with 40 hours of work per week (excluding lunch time), 22 days of annual leave (plus statutory days), healthcare coverage provided by the Spanish Social Security system and a Private Accident Insurance.
Please note that all the candidates must either be in possession of a doctoral degree or have at least 4 years of full-time equivalent research experience at the corresponding deadline for submission of proposals.
Eligible applications will be forwarded to the Selection Committee, which will be integrated by the Scientific Director of CIBERDEM, several members of the International Scientific Committee of CIBERDEM and several other experts external to CIBERDEM, experienced in the diabetes field. Each application will be reviewed by two members of this committee, and the final score will be obtained by consensus. If any evaluator has a potential conflict of interests with an applicant, another member of the Selection Committee will take care of the corresponding evaluation.
The evaluators will score the applications according to the following criteria:
Aplicants with a score under 50 will not pass to the interviewing phase.
The best-scored applicants will be invited to a 30-40 min. interview with two members of the Seleccion Committee, differents to those who evaluated the applicant. The evaluators will score the interview according to the following criteria:
Only applicants with an added score over 80 will be considered.
Successful applicants will be chosen by the Selection Committee based on the final score obtained (90%) and the strategic needs of the CIBERDEM consortium (10%). The final ranked list will be published afterwards, and applicants will be contacted with detailed information regarding their selection process.
